Shandong University of Technology - China
Professional Profile
SCOPUS
ORCID
Early Academic Pursuits
Dr. Hina Khalid began her academic journey with a Bachelor of Science (BS) Honours in Bioinformatics from Government College University, Faisalabad, followed by a Master of Science (MS) in Biotechnology. She completed her Ph.D. in Biotechnology from the same institution in 2021, focusing on innovative approaches in molecular biology and immunoinformatics.
Professional Endeavors
Dr. Khalid's research career has been marked by significant contributions across various institutions. She served as a Research Associate at Government College University, Faisalabad, where she led projects investigating the therapeutic potential of synthetic compounds against Biotechnology Hepatitis C Virus (HCV). Her work integrated insilico approaches with experimental validations, employing molecular docking, Real-Time PCR, and western blotting techniques.
Contributions and Research Focus
Dr. Khalid's research interests span a wide array of disciplines within biotechnology and molecular biology. She has expertise in cell biology, microscopy/imaging, immunology, biochemistry, genomics, and bioinformatics. Her notable contributions include the development of novel Biotechnology therapies for HCV, insights into cancer stem cells in hepatocellular cancer, and the design of multi-epitope vaccines against viral infections using immunoinformatics approaches.
Accolades and Recognition
Dr. Khalid's research has been widely recognized through numerous publications in high-impact journals and several awards. She has authored papers on topics ranging from viral infections to cancer biology, showcasing her expertise in elucidating complex biological mechanisms and Biotechnology developing therapeutic interventions.
Impact and Influence
Dr. Khalid's work has had a profound impact on the fields of biotechnology and immunoinformatics, particularly in advancing the understanding of viral diseases and cancer biology. Her contributions in designing novel therapeutic strategies and vaccines reflect her commitment to Biotechnology addressing global health challenges through innovative research.
Legacy and Future Contributions
Dr. Khalid's legacy is characterized by her pioneering research in immunoinformatics and molecular biology, aimed at developing targeted therapies and vaccines. Her future contributions are poised to continue pushing the boundaries of biotechnological research, with a focus on enhancing disease prevention and treatment strategies. As she progresses in her career, Dr. Khalid remains dedicated to leveraging her Biotechnology expertise to make transformative advancements in healthcare and biotechnology.
NOTABLE PUBLICATIONS
Calcineurin and mTOR inhibitors in kidney transplantation: integrative metamodeling on transplant 2024